Want to collaborate with us?
Charlton Morris is a Talent Solutions business who offer search, contract, volume and employer branding solutions to the life science markets.Feature in podcasts, articles, videos and more.
In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Beth Cobb, Chief Operating Officer at NOWDiagnostics | NowDx.
NOWDx is on a mission to develop rapid, accurate, affordable, and easy-to-administer over-the-counter and point-of-care diagnostic tests that return results in minutes. This innovative product is accompanied by a vision to create a world with vastly improved access to accurate healthcare information. Through providing access to quick and easy at home testing, patients and caregivers become empowered with the knowledge and understanding to truly change the future of disease management.
In this episode, we discuss diversity and gender equality in the start-up and diagnostics space, and what this landscape means for the future of NOWDx and others in the market. Priding themselves on striving to make a difference to people's lives, both colleagues and customers, Beth delves into the challenges and strategies she has experiences when doing just that.
Whether you’re in the diagnostics industry or not, this episode promises invaluable insight for those looking to change their company DEI agenda for the better.
If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at nathan.sharpe@lifesci-cm.com or let's connect on LinkedIn.
Feature in podcasts, articles, videos and more.
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
Comments.